NCT01345669 · Interventional trial
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Overall registry status Terminated
Phase 3
Conditions Head and Neck Neoplasms
Delaware Valley sites
- 1200.131.00172 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory